Showing results (1281-1290 of 1,422) with videos related to

Sort By:
Pageof 143
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Proof of concept of a multimodal intravital molecular imaging system for tumour transpathology investigationZhen Liu, Tao Cheng, Stephan Düwel, et al.
Nature Immunology|July 29, 2020
Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infectionXuemei Xie, Qiang Shi, Peng Wu, et al.
BMC Genomics|February 17, 2024
Decoding the complexity of on-target integration: characterizing DNA insertions at the CRISPR-Cas9 targeted locus using nanopore sequencingJuan-Juan Zhao, Xin-Yu Sun, Sai-Ning Tian, et al.
Science China. Life Sciences|January 9, 2021
HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCsJian-Ping Zhang, Zhi-Xue Yang, Feng Zhang, et al.
Journal of Medicinal Chemistry|October 18, 2012
Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitorsPeng Yang, Kyaw-Zeyar Myint, Qin Tong, et al.
Bone Marrow Transplantation|December 6, 2019
PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient miceXiuxiu Yin, Linping Hu, Yawen Zhang, et al.
Oncotarget|October 31, 2015
High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survivalShuhua Yi, Dehui Zou, Chengwen Li, et al.
The Journal of Clinical Investigation|December 15, 2025
Leukemia-expanded splenic CD81+ erythroblasts potentiate disease progression in mice by reshaping leukemic cell metabolismYue Li, Jiaxuan Cao, Jingyuan Tong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 30, 2025
Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple MyelomaJian Cui, Jingwei Wang, Xiaoyun Li, et al.
Leukemia Research|April 22, 2014
Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survivalGang An, Huijun Wang, Xiaoqi Qin, et al.
Pageof 143